• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国食管癌高发地区基于人群的胃食管反流病调查。

A population-based survey of gastroesophageal reflux disease in a region with high prevalence of esophageal cancer in China.

机构信息

Department of Gastroenterology, Peking University Third Hospital, Beijing 100191, China.

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing 100142, China.

出版信息

Chin Med J (Engl). 2019 Jul 5;132(13):1516-1523. doi: 10.1097/CM9.0000000000000275.

DOI:10.1097/CM9.0000000000000275
PMID:31045906
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6616241/
Abstract

BACKGROUND

The exact relationship between gastroesophageal reflux disease (GERD) and esophageal squamous cell cancer (ESCC) is far from clarification. The aim of this study was to investigate the epidemiology of GERD in a region with high prevalence of ESCC in China.

METHODS

A population-based, cross-sectional study was conducted in a high ESCC prevalent area, Anyang, Henan, China. All subjects fulfilled questionnaires and underwent gastroendoscopy with routine esophageal biopsy. The subjects were divided into GERD subtypes (reflux esophagitis [RE] and non-erosive reflux disease [NERD]) and controls. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated to examine risk factors for RE and NERD.

RESULTS

A total of 2844 subjects were finally enrolled. The prevalence of GERD (RE + NERD) was 17.3%. Among them, 271 (9.53%) adults were diagnosed with RE. The prevalence of RE increased with age (7.09% in 45-50 years, 8.00% in 51-60 years, and 9.53% in 61-69 years, χ = 62.216, P < 0.001). Sixty-seven (2.36%) subjects were diagnosed with the silent RE. A total of 221 (7.77%) subjects were diagnosed with NERD. Frequent liquid food consumption (OR [95% CI]: 1.502 [1.076-2.095]) was independent risk factor for RE as well as age, male gender, high body mass index (BMI), ever smoking. Age was independent risk factor for NERD. For silent RE, age, male gender, and frequent liquid food consumption were risk factors.

CONCLUSIONS

In the population with high prevalence of ESCC, a high prevalence of GERD and inverted proportion of RE/NERD were presented. Age was an independent risk factor for GERD. The male gender, high BMI, smoking, and frequent liquid food consumption may be risk factors for RE but not for NERD.

摘要

背景

胃食管反流病(GERD)和食管鳞状细胞癌(ESCC)之间的确切关系尚不清楚。本研究旨在探讨中国 ESCC 高发地区 GERD 的流行病学。

方法

在河南省安阳市这一 ESCC 高发地区进行了一项基于人群的横断面研究。所有研究对象均完成了问卷调查,并接受了常规食管活检的胃镜检查。研究对象分为 GERD 亚型(反流性食管炎[RE]和非糜烂性反流病[NED])和对照组。计算比值比(OR)和 95%置信区间(CI)以检查 RE 和 NED 的危险因素。

结果

共纳入 2844 名研究对象,GERD(RE+NERD)的患病率为 17.3%。其中,271 名(9.53%)成年人被诊断为 RE。RE 的患病率随年龄增长而增加(45-50 岁为 7.09%,51-60 岁为 8.00%,61-69 岁为 9.53%,χ²=62.216,P<0.001)。67 名(2.36%)患者被诊断为无症状性 RE。221 名(7.77%)患者被诊断为 NERD。经常食用液体食物(OR[95%CI]:1.502[1.076-2.095])是 RE 的独立危险因素,也是年龄、男性、高体重指数(BMI)、吸烟史的独立危险因素。年龄是 NERD 的独立危险因素。对于无症状性 RE,年龄、男性和经常食用液体食物是危险因素。

结论

在 ESCC 高发人群中,GERD 患病率较高,RE/NERD 比例倒置。年龄是 GERD 的独立危险因素。男性、高 BMI、吸烟和经常食用液体食物可能是 RE 的危险因素,但不是 NERD 的危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3ff/6616241/8b2f28709be1/cm9-132-1516-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3ff/6616241/8b2f28709be1/cm9-132-1516-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3ff/6616241/8b2f28709be1/cm9-132-1516-g001.jpg

相似文献

1
A population-based survey of gastroesophageal reflux disease in a region with high prevalence of esophageal cancer in China.中国食管癌高发地区基于人群的胃食管反流病调查。
Chin Med J (Engl). 2019 Jul 5;132(13):1516-1523. doi: 10.1097/CM9.0000000000000275.
2
Background factors of reflux esophagitis and non-erosive reflux disease: a cross-sectional study of 10,837 subjects in Japan.日本 10837 例患者反流性食管炎和非糜烂性反流病的背景因素:一项横断面研究。
PLoS One. 2013 Jul 26;8(7):e69891. doi: 10.1371/journal.pone.0069891. Print 2013.
3
Incidence of gastroesophageal reflux disease in Uygur and Han Chinese adults in Urumqi.乌鲁木齐地区维吾尔族与汉族成年人胃食管反流病发病率比较。
World J Gastroenterol. 2012 Dec 28;18(48):7333-40. doi: 10.3748/wjg.v18.i48.7333.
4
Risk factors for gastroesophageal reflux disease, reflux esophagitis and non-erosive reflux disease among Chinese patients undergoing upper gastrointestinal endoscopic examination.接受上消化道内镜检查的中国患者中胃食管反流病、反流性食管炎和非糜烂性反流病的危险因素
World J Gastroenterol. 2007 Dec 7;13(45):6009-15. doi: 10.3748/wjg.v13.45.6009.
5
Differences in Dietary and Lifestyle Triggers between Non-Erosive Reflux Disease and Reflux Esophagitis-A Multicenter Cross-Sectional Survey in China.非糜烂性反流病和反流性食管炎饮食及生活方式触发因素的差异:中国多中心横断面调查。
Nutrients. 2023 Jul 31;15(15):3400. doi: 10.3390/nu15153400.
6
Different effects of dietary factors on reflux esophagitis and non-erosive reflux disease in 11,690 Korean subjects.在 11690 名韩国受试者中,饮食因素对反流性食管炎和非糜烂性反流病的影响不同。
J Gastroenterol. 2017 Jul;52(7):818-829. doi: 10.1007/s00535-016-1282-1. Epub 2016 Nov 15.
7
Determinants of symptoms in gastroesophageal reflux disease: nonerosive reflux disease, symptomatic, and silent erosive reflux disease.胃食管反流病症状的决定因素:非糜烂性反流病、有症状和无症状的糜烂性反流病。
Eur J Gastroenterol Hepatol. 2013 Jul;25(7):764-71. doi: 10.1097/MEG.0b013e32835f594c.
8
[A comparison of clinical characteristics between non-erosive reflux disease and reflux esophagitis].非糜烂性反流病与反流性食管炎临床特征的比较
Zhonghua Nei Ke Za Zhi. 2016 Jul 1;55(7):510-4. doi: 10.3760/cma.j.issn.0578-1426.2016.07.005.
9
Is there a difference in the prevalence of gastroesophageal reflux disease between peritoneal dialysis and hemodialysis patients?腹膜透析患者和血液透析患者的胃食管反流病患病率是否存在差异?
Korean J Gastroenterol. 2013 Oct;62(4):206-12. doi: 10.4166/kjg.2013.62.4.206.
10
Obesity is an independent risk factor for GERD symptoms and erosive esophagitis.肥胖是胃食管反流病症状和糜烂性食管炎的独立危险因素。
Am J Gastroenterol. 2005 Jun;100(6):1243-50. doi: 10.1111/j.1572-0241.2005.41703.x.

引用本文的文献

1
Gastroesophageal disease risk and inhalational exposure a systematic review and meta-analysis.胃食管疾病风险与吸入性暴露:一项系统评价与荟萃分析
Sci Rep. 2025 Jul 2;15(1):22581. doi: 10.1038/s41598-025-06620-7.
2
Risk factors and 26-years worldwide prevalence of endoscopic erosive esophagitis from 1997 to 2022: a meta-analysis.风险因素与 1997 年至 2022 年 26 年间全球范围内内镜下侵蚀性食管炎的患病率:一项荟萃分析。
Sci Rep. 2023 Sep 14;13(1):15249. doi: 10.1038/s41598-023-42636-7.
3
Tandem Mass Tag Analysis of the Effect of the Anterior Cingulate Cortex in Nonerosive Reflux Disease Rats with Shugan Jiangni Hewei Granules Treatment.

本文引用的文献

1
Association Between Anxiety and Depression and Gastroesophageal Reflux Disease: Results From a Large Cross-sectional Study.焦虑抑郁与胃食管反流病之间的关联:一项大型横断面研究的结果
J Neurogastroenterol Motil. 2018 Oct 1;24(4):593-602. doi: 10.5056/jnm18069.
2
Modern diagnosis of GERD: the Lyon Consensus.现代 GERD 诊断:里昂共识。
Gut. 2018 Jul;67(7):1351-1362. doi: 10.1136/gutjnl-2017-314722. Epub 2018 Feb 3.
3
Efficacy of endoscopic screening for esophageal cancer in China (ESECC): design and preliminary results of a population-based randomised controlled trial.
疏肝降逆和胃颗粒对非糜烂性反流病大鼠前扣带回皮质的影响的串联质量标签分析。
Comput Math Methods Med. 2022 Jul 30;2022:8104337. doi: 10.1155/2022/8104337. eCollection 2022.
4
Effects of Infection on the Oral Microbiota of Reflux Esophagitis Patients.感染对反流性食管炎患者口腔微生物群的影响。
Front Cell Infect Microbiol. 2021 Sep 16;11:732613. doi: 10.3389/fcimb.2021.732613. eCollection 2021.
5
Dietary and Lifestyle Factors Related to Gastroesophageal Reflux Disease: A Systematic Review.与胃食管反流病相关的饮食和生活方式因素:一项系统综述。
Ther Clin Risk Manag. 2021 Apr 15;17:305-323. doi: 10.2147/TCRM.S296680. eCollection 2021.
6
Mechanisms of Pharmaceutical Therapy and Drug Resistance in Esophageal Cancer.食管癌的药物治疗机制与耐药性
Front Cell Dev Biol. 2021 Feb 11;9:612451. doi: 10.3389/fcell.2021.612451. eCollection 2021.
7
Efficacy and safety of traditional Chinese herbal formula combined with western medicine for gastroesophageal reflux disease: A protocol for systematic review and meta-analysis.中药复方联合西药治疗胃食管反流病的疗效与安全性:系统评价与Meta分析方案
Medicine (Baltimore). 2020 Oct 9;99(41):e22454. doi: 10.1097/MD.0000000000022454.
8
Gastroesophageal reflux disease in a typical African population: a symptom-based multicenter study.在一个典型的非洲人群中胃食管反流病:一项基于症状的多中心研究。
BMC Gastroenterol. 2020 Apr 15;20(1):107. doi: 10.1186/s12876-020-01261-8.
中国内镜筛查食管癌的疗效(ESECC):一项基于人群的随机对照试验的设计和初步结果。
Gut. 2019 Feb;68(2):198-206. doi: 10.1136/gutjnl-2017-315520. Epub 2018 Jan 6.
4
Tobacco smoking, alcohol consumption and gastro-oesophageal reflux disease.吸烟、饮酒与胃食管反流病。
Best Pract Res Clin Gastroenterol. 2017 Oct;31(5):501-508. doi: 10.1016/j.bpg.2017.09.004. Epub 2017 Sep 7.
5
Epidemiology of Esophageal Squamous Cell Carcinoma.食管鳞状细胞癌的流行病学
Gastroenterology. 2018 Jan;154(2):360-373. doi: 10.1053/j.gastro.2017.08.023. Epub 2017 Aug 18.
6
Presentation and Epidemiology of Gastroesophageal Reflux Disease.胃食管反流病的临床表现与流行病学
Gastroenterology. 2018 Jan;154(2):267-276. doi: 10.1053/j.gastro.2017.07.045. Epub 2017 Aug 3.
7
[Analysis of the incidence and age characteristics of upper gastrointestinal cancer among 2003-2012 in the high incidence area of esophageal cancer, Cixian County, in Hebei Province].[河北省磁县食管癌高发区2003 - 2012年上消化道癌发病情况及年龄特征分析]
Zhonghua Yu Fang Yi Xue Za Zhi. 2017 May 6;51(5):398-402. doi: 10.3760/cma.j.issn.0253-9624.2017.05.006.
8
Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis.全球幽门螺杆菌感染率:系统评价和荟萃分析。
Gastroenterology. 2017 Aug;153(2):420-429. doi: 10.1053/j.gastro.2017.04.022. Epub 2017 Apr 27.
9
A Model To Identify Individuals at High Risk for Esophageal Squamous Cell Carcinoma and Precancerous Lesions in Regions of High Prevalence in China.中国高发地区食管鳞癌及癌前病变高危人群识别模型。
Clin Gastroenterol Hepatol. 2017 Oct;15(10):1538-1546.e7. doi: 10.1016/j.cgh.2017.03.019. Epub 2017 Mar 23.
10
Epidemiology and natural history of gastroesophageal reflux disease.胃食管反流病的流行病学及自然史
Minerva Gastroenterol Dietol. 2017 Sep;63(3):175-183. doi: 10.23736/S1121-421X.17.02383-2. Epub 2017 Feb 17.